Biote Stock (NASDAQ: BTMD) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 113.507K |
Day Range | - - - |
52 Wk Range | 3.654 - 8.220 |
Market Cap | $200.992M |
P/E Ratio | 42.769 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 3.32% |
Days to Cover | 6.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biote (NASDAQ: BTMD) through any online brokerage.
Other companies in Biote’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Terns Pharma (NASDAQ:TERN) and Rani Therapeutics Hldgs (NASDAQ:RANI).
The latest price target for Biote (NASDAQ: BTMD) was reported by Roth MKM on Wednesday, March 13, 2024. The analyst firm set a price target for 9.00 expecting BTMD to rise to within 12 months (a possible 62.16% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Biote (NASDAQ: BTMD) is $5.55 last updated April 22, 2024 at 4:02 PM EDT.
There are no upcoming dividends for Biote.
Biote’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Biote.
Biote is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.